Matthew King
Managing Partner @ FCA Venture Partners
Brentwood, United States
Matthew King is a Series A investor at FCA Venture Partners in Brentwood focused on Health Care and Software. Mr. King oversees the Fund’s investment process including identifying potential investments, due diligence, investment structuring, syndicate leadership, portfolio management, and dispositions. Within the FCA Funds, Mr. King has previously served as a member and President of the general partner for FCA IV, and a member of the general partner forFCA III, serving on its investment committee.Mr. King has over 29 years of business experience, the last 12 of which have been focused exclusively in the venture capital industry. He has participated in over 50 venture capital and private equity investments since 1992 and has served as lead investor in 18 transactions for FCA III, FCA IV, and V. He currently serves on the Board of Directors of NuScript Rx, Inc., edo Interactive, Inc., Entrada Inc., onFocus Healthcare, Inc., Silvercare Solutions, Inc., LogoGarden, KeraFAST, Inc., and ProCharging Systems, LLC, and a Board Observer for HCCA International, Inc.Mr. King previously served as a Vice President of Third National Bank and its successor, SunTrust Bank (1983-1989), Chairman, President and CEO of Radar Business Systems, Inc. (1990-1996) and Regional Vice President of Radar’s successor company U.S. Office Products, Inc. (1996-1999). He also is a Founder and served as Chairman, President and CEO of MyOfficeProducts, Inc., a FCA III portfolio company, from 2001 to 2003.Mr. King currently serves as a Director of Nashville Bank & Trust Company, Director of Wake Forest University Health Sciences, Trustee for Wake Forest University and is a member of the Nashville Rotary Club.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 45%
Last updated:
For AI agents: llms.txt
Industries Matthew King invests in
Stages Matthew King invests in
Countries Matthew King invests in
Investment Focus
Industry
- Health Care 8 (36%)
- Software 6 (27%)
- Information Technology 4 (18%)
- Medical 3 (14%)
- Dental 2 (9%)
Stage
- Series A 9 (41%)
- Series B 4 (18%)
- Funding Round 3 (14%)
- Series C 2 (9%)
- Convertible Note 2 (9%)
Country
- United States 13 (59%)
- United Kingdom 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
InStockRx
|
Billions of dollars of prescription medications are wasted each year due to expiring inventory, overstock issues and the like. And, all too often patients can’t find the medications they need, even when the drug might be at another pharmacy close by.InStockRx solves this problem. We provide: a self-populating marketplace where pharmacies canbuy and sell with each other, a robust inventory analytics SaaS tool that pinpoints inventory issues and an in-stock drug search engine so pharmacies can easily find the drugs they need on the marketplace. Pharmacies buy and sell with each other today, but just don't have the right tools. With InStockRx, they do. | $5M / Series A / Jul 01, 2026 | |
IgniteData
|
Ignite is the UK’s leading provider of technology-driven Patient Recruitment and Real-World Evidence solutions. | $10.9M / Series A / Aug 14, 2025 | |
evolvedMD
|
EvolvedMD is leading the integration of behavioral health services in modern primary care. | $34M / Series B / Jul 14, 2025 | |
Vellum Health
|
Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients. | Series A / Jun 26, 2025 | |
|
evolvedMD
|
EvolvedMD is leading the integration of behavioral health services in modern primary care. | $14M / Series A / Jun 13, 2023 | |
Enable Dental
|
On-premise dental solutions for in-need populations empowering dental clinicians to deliver care to patients who need it the most. | Series A / Jan 21, 2020 | |
Vivante Health
|
Since 2016, Vivante Health has been revolutionizing digestive health and wellness, one person at a time. Our category-defining digital health solutions provide personalized, comprehensive care for people with digestive conditions. Our all-in-one digestive health program GIThrive® combines clinically-backed interactive tech, targeted nutrition, and24/7 personal support to improve digestive disease outcomes, and reduce the cost of care. GIThrive is used by large employers and health plans to reduce the costs of chronic disease, improve employee health, and workplace absenteeism. | Series A / Dec 10, 2018 | |
iDentalSoft
|
iDentalSoft is the leading SaaS dental practice management platform, enabling any sized dental practice to operate more efficiently and grow their business. Our comprehensive features help attract more patients, fill vacancies faster, complete tasks rapidly, and dramatically reduce IT costs and headaches. The software is device/hardwareagnostic and configured to each dental office's unique workflow to ensure it's easy to use and always secure for staff and patients. | Jun 13, 2018 | |
Catavolt
|
Catavolt makes the power of cloud applications accessible to the business world. Their unique Hybrid Cloud approach uses patent-pending technology to enable enterprises to gain worldwide access to their data from smartphones, widgets, tablets, and desktops. They make this possible without disrupting existing systems or moving data outside of thedata center. The result is a fast, low-cost, low-risk implementation that makes businesses more agile and better suited to respond to the needs and expectations of today's world. Companies both large and small are using Catavolt to build their own corporate cloud and connect with their network of customers, partners, suppliers, and employees. | Convertible Note / May 27, 2016 | |
Clinical Ink
|
Clinical Ink, Inc. provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol-specific eSource documents, as well as captures the data required by the protocol. The company also provides an electronicsource record (ESR) for clinical trials that provides cleaner data. In addition, it offers hosting services. Clinical Ink was founded in 2006 and is based in Winston-Salem, North Carolina. | Series C / Feb 23, 2016 | |
| See all 22 investments → | |||
Co-Investors
FCA Venture Partners
5 deals together
Nashville Capital Network
4 deals together
Claritas Capital
2 deals together
Clayton Associates
2 deals together
Conductive Ventures
2 deals together
Council Capital
2 deals together
About FCA Venture Partners
Founded in 1996, FCA Venture Partners has a long history of investing in successful healthcare entrepreneurs. The firm is passionate about building sustainable businesses and providing strategic value to their portfolio companies. FCA invests $3-6M in fast growing healthcare companies making processes in the industry faster, better, and cheaperwhile improving the quality of care and the patient experience. With its location in Nashville, roots with Clayton Associates and the McWhorter Family, and deep involvement in the growth of the U.S. healthcare community, FCA Venture Partners is poised to take advantage of disruptive opportunities that help move healthcare forward.
FCA Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Bouldin
Partner
|
|||
George Curran
Associate
|
|||
John R. Burch
Managing Partner
|
|||
|
Matthew King
Managing Partner
|
|||
Nancy S. Allen
Partner & CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Matthew King invest in?
Matthew King invests primarily in Health Care, Software and Information Technology startups, most often at Series A and Series B stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Matthew King last invest?
The most recent investment recorded for Matthew King closed in Jul 2026. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
